| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RecQ like helicase 4 | 0.496 | 0.808 | 3.3E-35 |
|
disease | 0.300 | limited | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
tetratricopeptide repeat domain 7A | 0.641 | 0.577 | 1.5E-31 |
|
disease | 0.330 | strong | 1.000 | 1 | 0 | 2013 | 2014 | ||||||||
|
regulatory factor X5 | 0.650 | 0.577 | 2.0E-11 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
signal transducer and activator of transcription 1 | 0.399 | 0.885 | 1.00 |
|
disease | 0.450 | strong | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
signal transducer and activator of transcription 5A | 0.445 | 0.808 | 1.00 |
|
disease | 0.300 | limited | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
stromal interaction molecule 1 | 0.501 | 0.808 | 0.78 |
|
disease | 0.330 | strong | 1.000 | 1 | 0 | 2016 | 2019 | ||||||||
|
serine/threonine kinase 4 | 0.638 | 0.462 | 1.5E-02 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2014 | 2015 | ||||||||
|
transferrin receptor | 0.437 | 0.885 | 7.0E-05 |
|
disease | 0.400 | limited | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
CD70 molecule | 0.542 | 0.692 | 1.0E-02 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
dedicator of cytokinesis 8 | 0.578 | 0.731 | 1.5E-11 |
|
disease | 0.400 | strong | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
magnesium transporter 1 | 0.548 | 0.769 | 0.96 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
caspase recruitment domain family member 11 | 0.582 | 0.615 | 1.00 |
|
disease | 0.320 | strong | 1.000 | 1 | 0 | 2013 | 2018 | ||||||||
|
ORAI calcium release-activated calcium modulator 1 | 0.520 | 0.808 | 1.9E-05 |
|
disease | 0.320 | strong | 1.000 | 1 | 0 | 2009 | 2018 | ||||||||
|
unc-119 lipid binding chaperone | 0.691 | 0.462 | 1.5E-04 |
|
disease | 0.300 | limited | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
CD3g molecule | 0.695 | 0.346 | 1.7E-05 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
CD27 molecule | 0.517 | 0.692 | 1.0E-02 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2013 | 2015 | ||||||||
|
protein kinase, DNA-activated, catalytic subunit | 0.540 | 0.808 | 1.00 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
phosphoinositide-3-kinase regulatory subunit 1 | 0.477 | 0.885 | 1.00 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.340 | strong | 1.000 | 1 | 0 | 2013 | 2019 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
inhibitor of nuclear factor kappa B kinase subunit beta | 0.506 | 0.846 | 0.99 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
inducible T cell costimulator | 0.502 | 0.731 | 3.1E-02 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
T cell receptor alpha constant | 0.691 | 0.615 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 1986 | 1986 | |||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2014 | 2014 |